VeriChip Corporation Partners With U.S. Living Will Registry as Advance Directive Resource
March 27 2007 - 9:30AM
PR Newswire (US)
Partnership Provides Healthcare Professionals Access to Advance
Directives through VeriMed Patient Identification System DELRAY
BEACH, Fla., March 27 /PRNewswire-FirstCall/ -- VeriChip
Corporation (NASDAQ:CHIP) today announced it entered into a
Community Partnership Agreement with U.S. Living Will Registry(R)
that enables healthcare professionals to view the Advance
Directives of patients enrolled in the VeriMed Patient
Identification System via a secure link within the VeriMed Patient
Registry. This will be the first completely digital link to a
national Advance Directive document archive. Utilizing the U.S.
Living Will Registry's proprietary software platform and the
VeriMed Patient Registry, VeriMed subscribers will be able to
register their advance directives and organ donation information.
Scott R. Silverman, Chairman and Chief Executive Officer of
VeriChip Corporation, commented, "We are pleased to provide direct
access to electronic advance directive documents stored at the U.S.
Living Will Registry via the VeriMed Patient Identification System.
This permits hospitals and health systems with our VeriMed RFID
Reader to quickly and easily view these vital documents." "Our
system is designed to be scalable for individuals from all states,
health systems, insurers and national organizations. We provide a
safe and secure place to store the documents, and make them
available 24 hours a day wherever they are needed," said Dr. Joseph
T. Barmakian, who founded the U.S. Living Will Registry in 1996.
"VeriMed is taking a leadership position in ensuring ready access
to important advance directives, and we are excited to be their
partner in providing this valuable service," continued Barmakian.
Advance directives, commonly known as living wills and health care
proxies, are legal documents that allow a person to make their
health care wishes known if they are incapacitated and unable to
make decisions for themselves. In a health care proxy (health care
power of attorney), a person names someone to make decisions for
them. Interest in advance directives increased dramatically with
nationwide attention to the case of Floridian Terri Schiavo. Ms.
Schiavo was in a chronic vegetative state, and did not have an
advance directive. The national attention to Ms. Schiavo's case
prompted many to prepare their own advance directive in order to
spare their families a similar fate. About U.S. Living Will
Registry The U.S. Living Will Registry is the leading provider of
advance directive management services in the country. Providing
this service for more than ten years, The U.S. Living Will Registry
is the largest secure web-based repository of advance directive
documents in North America. For more information, visit
http://www.uslivingwillregistry.com/. About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida,
develops, markets and sells radio frequency identification, or
RFID, systems used to identify, locate and protect people and
assets. VeriChip's goal is to become the leading provider of RFID
systems for people in the healthcare industry. VeriChip sells
passive RFID systems for identification purposes and active RFID
systems for local-area location and identification purposes.
VeriChip recently began to market its VeriMed(TM) Patient
Identification System for rapidly and accurately identifying people
who arrive in an emergency room and are unable to communicate. This
system uses the first human-implantable passive RFID microchip, the
implantable VeriChip(TM), cleared for medical use in October 2004
by the United States Food and Drug Administration. VeriChip
Corporation is majority-owned by Applied Digital Solutions Inc.
(NASDAQ:ADSX), which also owns a majority position in Digital Angel
Corporation. For more information on VeriChip, please call
1-800-970-2447, or email . Additional information can be found
online at http://www.verichipcorp.com/. Statements about the
Company's future expectations, including future revenues and
earnings, and all other statements in this press release other than
historical facts are "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, Section 21E
of the Securities Exchange Act of 1934, and as that term is defined
in the Private Litigation Reform Act of 1995. Such forward-looking
statements involve risks and uncertainties and are subject to
change at any time, and the Company's actual results could differ
materially from expected results. The Company undertakes no
obligation to update forward-looking statements to reflect
subsequently occurring events or circumstances. Contact: VeriChip
Corporation The Ruth Group Allison Tomek Nick Laudico (investors)
561-805-8000 (646) 536-7030 Jason Rando (media) (646) 536-7025
DATASOURCE: VeriChip Corporation CONTACT: Allison Tomek of VeriChip
Corporation, +1-561-805-8000, ; or investors, Nick Laudico,
+1-646-536-7030, , or media, Jason Rando, +1-646-536-7025, , both
of The Ruth Group, for VeriChip Corporation Web site:
http://www.verichipcorp.com/ http://www.uslivingwillregistry.com/
Copyright
Applied Digital Solutions (NASDAQ:ADSX)
Historical Stock Chart
From Apr 2024 to May 2024
Applied Digital Solutions (NASDAQ:ADSX)
Historical Stock Chart
From May 2023 to May 2024